1. A case of hyperprogression of lung cancer following atezolizumab. (January 2019) Authors: Muthukumar, D.; Saunders, E.; Rubasingham, J.; Nagarajah, V. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single centre experience of anti-PDL1 and anti-PD1 agents in treatment of non-small cell lung cancer (NSCLC). (January 2019) Authors: Saunders, E.; Rubasingham, J.; Muthukumar, D.; Ingle, C. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Audit of 30-day mortality following palliative radiotherapy at Southend University Hospital. (October 2019) Authors: Denholm, M.; Cooper, S.; Malek, A.; Rubasingham, J.; Mithra, S.; Tsang, D. Journal: Clinical oncology Issue: Volume 31(2019)Supplement 1 Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Developing a nurse consultant-led immunotherapy services in a district general hospital. (January 2019) Authors: Muthukumar, D.; Sheen, L.; Rubasingham, J.; Saunders, E. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-world Factors Predicting Complete Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer. Issue 7 (July 2019) Authors: Rubasingham, J.; Loo, V. Journal: Clinical oncology Issue: Volume 31:Issue 7(2019) Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗